Activin and Inhibin

IHMT-PI3Kδ-372 is a potent and selective PI3Kδ inhibitor with an IC 50 of 14 nM. IHMT-PI3Kδ-372 shows high selectivity over other class I PI3Ks (56∼83 fold) and other protein kinases. IHMT-PI3Kδ-372 can be uesd for chronic obstructive pulmonary

IHMT-PI3Kδ-372 is a potent and selective PI3Kδ inhibitor with an IC 50 of 14 nM. IHMT-PI3Kδ-372 shows high selectivity over other class I PI3Ks (56∼83 fold) and other protein kinases. IHMT-PI3Kδ-372 can be uesd for chronic obstructive pulmonary

IHMT-PI3Kδ-372 is a potent and selective PI3Kδ inhibitor with an IC 50 of 14 nM. IHMT-PI3Kδ-372 shows high selectivity over other class I PI3Ks (56∼83 fold) and other protein kinases. IHMT-PI3Kδ-372 can be uesd for chronic obstructive pulmonary

IHMT-PI3Kδ-372 is a potent and selective PI3Kδ inhibitor with an IC 50 of 14 nM. IHMT-PI3Kδ-372 shows high selectivity over other class I PI3Ks (56∼83 fold) and other protein kinases. IHMT-PI3Kδ-372 can be uesd for chronic obstructive pulmonary

IHVR-11029 is a small molecule inhibitor of ER α-glucosidases , with an EC 50 of 0.09 μMIn VitroIHVR-11029 exhibits EC 50 values of 1.3 μM, 3.3 μM and 0.75 μM for BVDV, TARV and DENV, respectively. MCE has not independently confirmed the accuracy of

IHVR-11029 is a small molecule inhibitor of ER α-glucosidases , with an EC 50 of 0.09 μMIn VitroIHVR-11029 exhibits EC 50 values of 1.3 μM, 3.3 μM and 0.75 μM for BVDV, TARV and DENV, respectively. MCE has not independently confirmed the accuracy of

IHVR-11029 is a small molecule inhibitor of ER α-glucosidases , with an EC 50 of 0.09 μMIn VitroIHVR-11029 exhibits EC 50 values of 1.3 μM, 3.3 μM and 0.75 μM for BVDV, TARV and DENV, respectively. MCE has not independently confirmed the accuracy of

IHVR-11029 is a small molecule inhibitor of ER α-glucosidases , with an EC 50 of 0.09 μMIn VitroIHVR-11029 exhibits EC 50 values of 1.3 μM, 3.3 μM and 0.75 μM for BVDV, TARV and DENV, respectively. MCE has not independently confirmed the accuracy of

IHVR-19029 is a potent endoplasmic reticulum (ER) α-glucosidases I and II inhibitor, with an IC 50 of 0.48 μM for ER a-glucosidase I. IHVR-19029 efficiently blocks the replication of several hemorrhagic fever viruses, such as Dengue virus (DENV),

IHVR-19029 is a potent endoplasmic reticulum (ER) α-glucosidases I and II inhibitor, with an IC 50 of 0.48 μM for ER a-glucosidase I. IHVR-19029 efficiently blocks the replication of several hemorrhagic fever viruses, such as Dengue virus (DENV),

IHVR-19029 is a potent endoplasmic reticulum (ER) α-glucosidases I and II inhibitor, with an IC 50 of 0.48 μM for ER a-glucosidase I. IHVR-19029 efficiently blocks the replication of several hemorrhagic fever viruses, such as Dengue virus (DENV),

IHVR-19029 is a potent endoplasmic reticulum (ER) α-glucosidases I and II inhibitor, with an IC 50 of 0.48 μM for ER a-glucosidase I. IHVR-19029 efficiently blocks the replication of several hemorrhagic fever viruses, such as Dengue virus (DENV),